These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7020139)

  • 1. Nonspecific enhancement of host defenses against infection: experimental evidence of a new order of efficacy and safety.
    Polk HC; Calhoun JH; Lowrey LD; Blanchard SP; Brewer RJ; Adams ST; Chedid L
    Surgery; 1981 Aug; 90(2):376-80. PubMed ID: 7020139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonspecific enhancement of resistance to local bacterial infection in starved mice.
    Galland RB; Trachtenberg LS; Rynerson N; Polk HC
    Arch Surg; 1982 Feb; 117(2):161-4. PubMed ID: 7034676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of nonspecific immunity to Klebsiella pneumoniae infection by a synthetic immunoadjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine) and several analogs.
    Chedid L; Parant M; Parant F; Lefrancher P; Choay J; Lederer E
    Proc Natl Acad Sci U S A; 1977 May; 74(5):2089-93. PubMed ID: 325566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The enhancement of host defenses against infection--search for the Holy Grail?
    Polk HC
    Surgery; 1986 Jan; 99(1):1-6. PubMed ID: 3941994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-specific stimulation of host defenses against a bacterial challenge in malnourished hosts.
    Galland RB; Polk HC
    Br J Surg; 1982 Nov; 69(11):665-8. PubMed ID: 6751460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonspecific stimulation of host defenses against bacterial challenge in immunosuppressed mice.
    Galland RB; Heine KJ; Polk HC
    Arch Surg; 1983 Mar; 118(3):333-7. PubMed ID: 6824433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of the neonate's nonspecific immunity to Klebsiella infection by muramyl dipeptide, a synthetic immunoadjuvant.
    Parant M; Parant F; Chedid L
    Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3395-9. PubMed ID: 356054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo and in vitro stimulation of nonspecific immunity by the beta-D-p-aminophenyl glycoside of N-acetylmuramyl-L-alanyl-D-isoglutamine and an oligomer prepared by cross-linking with glutaraldehyde.
    Parant M; Damais C; Audibert F; Parant F; Chedid L; Sache E; Lefrancier P; Choay J; Lederer E
    J Infect Dis; 1978 Sep; 138(3):378-86. PubMed ID: 100563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fate of two 14C labelled muramyl peptides: Ac-Mur-L-Ala-gamma-D-Glu-meso-A2pm and Ac-Mur-L-Ala-gamma-D-Glu-meso-A2pm-D-Ala-D-Ala in mice. Evaluation of their ability to increase non specific resistance to Klebsiella infection.
    Yapo A; Petit JF; Lederer E; Parant M; Parant F; Chedid L
    Int J Immunopharmacol; 1982; 4(3):143-9. PubMed ID: 7049971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of indomethacin on increased resistance to bacterial infection and on febrile responses induced by muramyl dipeptide.
    Parant M; Riveau G; Parant F; Dinarello CA; Wolff SM; Chedid L
    J Infect Dis; 1980 Nov; 142(5):708-15. PubMed ID: 7462686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amelioration by muramyl dipeptide of the effect of induced hyperferremia upon Klebsiella infection in mice.
    Brewer RJ; Galland RB; Polk HC
    Infect Immun; 1982 Oct; 38(1):175-8. PubMed ID: 6754611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological activities of muramyl dipeptide, a synthetic glycopeptide analogous to bacterial immunoregulating agents.
    Chedid L; Audibert F; Johnson AG
    Prog Allergy; 1978; 25():63-105. PubMed ID: 362430
    [No Abstract]   [Full Text] [Related]  

  • 13. Stimulatory effects of muramyl dipeptide upon neutrophils isolated from a local bacterial infection.
    Lamont PM; Maier KG; Melton L; Polk HC
    Br J Exp Pathol; 1987 Oct; 68(5):655-61. PubMed ID: 3318904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of tumoricidal properties in murine macrophages by intravenous injection of muramyl dipeptide encapsulated within liposomes as a treatment for spontaneous metastasis.
    Fidler IJ; Poste G
    Prog Clin Biol Res; 1981; 75B():257-67. PubMed ID: 7323097
    [No Abstract]   [Full Text] [Related]  

  • 15. Containment as a mechanism of nonspecific enhancement of defenses against bacterial infection.
    Polk HC; Lamont PM; Galland RB
    Infect Immun; 1990 Jun; 58(6):1807-11. PubMed ID: 2187809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of the local inflammatory response to bacterial infection by muramyl dipeptide.
    Lamont PM; Schrodt GR; Galland RB; Kaufman CM; Cheadle WG; Polk HC
    Br J Exp Pathol; 1984 Jun; 65(3):319-25. PubMed ID: 6743532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muramyl dipeptide stimulation of particle clearance in several animal species.
    Waters RV; Ferraresi RW
    J Reticuloendothel Soc; 1980 Nov; 28(5):457-71. PubMed ID: 7441647
    [No Abstract]   [Full Text] [Related]  

  • 18. Biological activity of a new synthetic muramyl peptide adjuvant devoid of pyrogenicity.
    Chedid LA; Parant MA; Audibert FM; Riveau GJ; Parant FJ; Lederer E; Choay JP; Lefrancier PL
    Infect Immun; 1982 Feb; 35(2):417-24. PubMed ID: 7035362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of bestatin and muramyl-dipeptide on macrophage-bound aminopeptidase.
    Wachsmuth ED; Wüst B
    Hoppe Seylers Z Physiol Chem; 1981 May; 362(5):563-8. PubMed ID: 7250904
    [No Abstract]   [Full Text] [Related]  

  • 20. Recent advances concerning the use of muramyl dipeptide derivatives as vaccine potentiators.
    Audibert F; Chedid L
    Prog Clin Biol Res; 1980; 47():325-38. PubMed ID: 7010376
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.